APOL1 gene variants are strongly associated with risk for focal segmental glomerulosclerosis (FSGS), HIV-associated nephropathy (HIVAN), and hypertension-attributed kidney disease (arterionephrosclerosis) [1]. Here, APOL1 is linked to kidney disorder.